Recent developments in drug hypersensitivity in children. (3rd July 2019)

• Record Type: Journal Article
• Authors: Kulhas Celik, Ilknur; Dibek Misirlioglu, Emine; Kocabas, Can Naci
• Is Part Of: Expert review of clinical immunology. Volume 15:Number 7(2019)
• Page Start: 723
• Page End: 733
• Publication Date: 2019-07-03
• Subjects: Children -- drug hypersensitivity -- drug allergy -- management -- recent developments; Clinical immunology -- Periodicals; 616.079
• DOI: 10.1080/1744666X.2019.1612241
• Languages: English
• ISSNs: 1744-666X

Abstract

ABSTRACT: Introduction : Drug allergy is an important public health problem that causes 0.4–10.3% of hospital admissions in children. The epidemiology, clinical spectrum, diagnosis, and management of drug hypersensitivity reactions (DHRs) differ in pediatric and adult patients. However, the same algorithms used in adults have often been applied in the pediatric population due to a lack of evidence in the literature. Areas covered : In this review, we aimed to discuss recent developments in the area of pediatric DHRs based on the growing body of literature advancing our understanding of the epidemiology, clinical aspects, and diagnostic approaches to DHRs in children. Expert opinion : Misdiagnosis, under-diagnosis, and self-diagnosis are common problems related to drug allergies in children. Viral infections are particularly frequent in children and make diagnosis difficult. Identifying true DHR is a key step in the management of drug allergy in children. Therefore, a complete allergy work-up with standardized drug allergy tests is necessary. In order to eliminate non-standardized tests, future studies including larger numbers of children should be conducted to determine more accurate standardized tests for diagnosing DHRs in the pediatric population.